Arterial Hypertension in Acromegaly: Altered Dopaminergic Control of Aldosterone Secretion

References

• Cain J. P., Williams G. H., Dluhy R. G. Plasma renin activity and aldosterone secretion in patients with acromegaly. J Clin Endocrinol Metab. 1972; 34: 73–81
   PubMed Web of Science ®Google Scholar
• Snow M. H., Piercy D. A., Robson V., Wilkinson R. An investigation into the pathogenesis of hypertension in acromegaly. Clin Sci Mol Med. 1977; 53: 87–91
   PubMedGoogle Scholar
• Strauch G., Vallotton M. B., Touitou Y., Bricaire H. The renin-angiotensin-aldosterone system in normotensive and hypertensive patients with acromegaly. N Engl J Med. 1972; 287: 795–799
   PubMed Web of Science ®Google Scholar
• Moore T. J., Thein-Wai W., Dluhy R. G., Dawson -Hughes B. F., Hollenberg N. K., Williams G. H. Abnormal adrenal and vascular responses to angiotensin II and an angiotensin antagonist in acromegaly. J Clin Endocrinol Metab. 1980; 51: 215–222
   PubMed Web of Science ®Google Scholar
• Norbiato G., Bevilacqua M., Raggi U., Micossi P., Moroni C. Metoclopramide increases plasma aldosterone concentration in man. J Clin Endocrinol Metab. 1977; 45: 1313–1316
   PubMed Web of Science ®Google Scholar
• Schambelan M., Sebastian A., Biglieri G., Hernandez R. Interaction of potassium on the renin-angiotensin system in the control of aldosterone secretion in normal and pathophysiologic states. Proc Seventh Internat Cong Endocrinol, Quebec, 1984; 217
   Google Scholar
• Whitfield L., Sowers J. R., Tuck M. L., Golub M. S. Dopaminergic control of plasma aldosterone responses to acute stimuli in normal man. J Clin Endocrinol Metab. 1980; 51: 724–729
   PubMed Web of Science ®Google Scholar
• Chiodini P. G., Liuzzi A., Botalla L., Cozzi R., Oppizzi G., Verde G. Dopamine and GH secretion in physiological conditions and in acromegaly. Neuroendocrinology: Biological and Clinical Aspects, A. Polleri, R. M. MacLeod. Academic Press, London 1979; 197–210
   Google Scholar
• Van Loon G. R. Abnormal plasma catecholamine responses in acromegalics. J Clin Endocrinol Metab 1979; 48: 784–789
   PubMed Web of Science ®Google Scholar
• Carey R. M., Thorner M. O., Ortt E. M. Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. J Clin Invest. 1979; 63: 727–735
   PubMed Web of Science ®Google Scholar
• Gilchirst N. L., Espiner E. A., Nicholls M. G., Donald R. A. Effect of metoclopramide on aldosterone and regulatory factors in man. Clin Endocrinol. 1984; 21: 1–7
   PubMed Web of Science ®Google Scholar
• Sowers J. R., Brickman A. S., Sowers D. K., Berg G. Dopaminergic modulation of aldosterone secretion in man is unaffected by glucocorticoids and angiotensin blockade. J Clin Endocrinol Metab. 1981; 52: 1078–1084
   PubMed Web of Science ®Google Scholar
• Sowers J. R., Golub M. S., Berger M. E., Whitfield L. A. Dopaminergic modulation of pressor and hormonal responses in essential hypertension. Hypertension 1982; 4: 424–430
   PubMed Web of Science ®Google Scholar
• Birkhauser M., Riondel A. M., Vallotton M. B. Bromocriptine-induced modulation of plasma aldosterone responses to acute stimulation. Acta Endocrinol. 1979; 91: 294–302
   PubMedGoogle Scholar
• Jeske W. The effect of metoclopramide, TRH and L-dopa on prolactin secretion in pituitary adenoma and “functional” galactorrhea syndrome. Acta Endocrinol. 1979; 91: 385–396
   PubMedGoogle Scholar
• Sowers J. R., Berg G., Tuck M. L., Martin V., Chandler D., Mayes D. Dopaminergic modulation in 18-hydroxycorticosterone secretion in man. J Clin Endocrinol Metab. 1982; 54: 528–534
   PubMed Web of Science ®Google Scholar
• Edwards C. R. W., Al-Dujaili E. A. S., Boscaro M., Quyyumi S., Miall P. A., Rees L. In vivo and in vitro studies on the effect of metoclopramide on aldosterone secretion. Clin Endocrinol. 1980; 13: 45–50
   PubMed Web of Science ®Google Scholar
• Zanella M. T., Bravo E. L. In vitro and in vivo evidence for an indirect mechanism mediating enhanced aldosterone secretion by metoclopramide. Endocrinology 1982; 111: 1620–1625
   PubMed Web of Science ®Google Scholar
• Carey R. M., Thorner M. O., Ortt E. M. Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine. J Clin Invest. 1980; 66: 10–18
   PubMed Web of Science ®Google Scholar
• Noth R. H., McCallum R. W., Contino C., Havelick J. Tonic dopaminergic suppression of plasma aldosterone. J Clin Endocrinol Matab. 1980; 51: 64–69
   PubMed Web of Science ®Google Scholar
• Sowers J. R., Martin V., Stern N., Berg G. Dopaminergic control of 18-hydroxycorticosterone responses to posture, isometric exercise and diuretic administration in normal man. J Clin Endocrinol Metab. 1982; 55: 475–480
   PubMed Web of Science ®Google Scholar
• Dunn M., Bosman H. Peripheral dopamine receptor identification: properties of a specific dopamine receptor in the rat adrenal zona glomerulosa. Biochem Biophys Res Commun. 1981; 99: 1081–1087
   PubMed Web of Science ®Google Scholar
• Cavero I., Massingham R., Borg F. Lefevre — Peripheral dopamine receptors, potential targets for a new class of anti-hypertensive agents. I. Subclassification and functional description. Life Sci. 1982; 31: 939–948
   PubMed Web of Science ®Google Scholar
• Stoof J. C., Kebabian J. W. Two dopamine receptors biochemistry, physiology and pharmacology. Life Sci. 1984; 35: 2281–2296
   PubMed Web of Science ®Google Scholar
• Mancini A. M., Guitelman A., Vargas C. A., Debeljuk D. L., Aparicio N. J. Effect of sulpiride on serum prolactin levels in humans. J Clin Endocrinol Metab. 1976; 42: 181–184
   PubMed Web of Science ®Google Scholar
• Spitz J., Borzilai D., Luboshitzky R. Diminished prolactin reserve in acromegaly. Metabolism 1980; 29: 880–885
   PubMed Web of Science ®Google Scholar
• Kanie N., Kageyama N., Kuwayama A., Nakane I., Watanabe M., Kawaoi A. Pituitary adenomas in acromegalics patients: an immunohistochemical and endocrinological study with special reference to prolactin-secreting adenoma. J Clin Endocrinol Metab. 1983; 57: 1093–1101
   PubMed Web of Science ®Google Scholar
• Stumpe K. O., Kolloch R., Higuchi M., Kruck F., Vetter H. Hyperprolactinemia and antihypertensive effect of bromocriptine in essential hypertension. Lancet 1980; 2: 211–214
   Google Scholar
• Saruta I., Kawabe H., Fujimaki M., Nagahama S., Saito I., Kondo K. Prolactin, renin and catecholamines in essential hypertension. Clin Exper Hypertension 1988; 5: 531–541
   Google Scholar
• Sowers J. R., Nyby M., Jasberg K. Dopaminergic control of prolactin and blood pressure: altered control in essential hypertension. Hypertension 1982; 4: 431–438
   PubMed Web of Science ®Google Scholar
• Coste G., Frisine N., De Pasquale R. Increased aldosterone secretion induced by sulpiride. Clin Endocrinol. 1980; 13: 1–7
   PubMed Web of Science ®Google Scholar
• Sowers J. R., Sharp B., McCallum R. W. Effect of domperidone, an extracerebral inhibitor of dopamine receptors, on thyrotropin, prolactin, renin, aldosterone, and 18-hyroxycorticosterone secretion in man. J Clin Endocrinol Metab. 1982; 54: 869–871
   PubMed Web of Science ®Google Scholar
• Stern N., Tuck M., Ozaki L., Krall F. Dopaminergic binding and inhibitory effect in the bovine adrenal zona glomerulosa. Hypertension 1986; 8: 203–210
   PubMed Web of Science ®Google Scholar
• Sowers J. R., Golub M. S., Eggena P. H., Catania R. A. Influence of sodium homeostasis on dopaminergic modulation of aldosterone, renin and prolactin secretion in man. J Clin Endocrinol Matab 1982; 54: 121–126
   PubMed Web of Science ®Google Scholar
• Sowers J. R., Stern N. Influence of sodium homeostasis and circadian rhythm on dopaminergic modulation of 18-hydroxycorticosterone secretion in man. J Clin Endocrinol Metab. 1982; 55: 1046–1051
   PubMed Web of Science ®Google Scholar
• Davies D., Beastall G., Connell J., Fraser R., Cruden D., Teasolate G. Body composition, blood pressure and the renin-angiotensin system in acromegaly. Proc Second Europ Meeting Hypertension, Milan, 1985; 123
   Google Scholar
• Rayfield E., Rose L., Dluhy R. G., Williams G. H. Aldosterone secretory and glucocorticoid excretory responses to alpha 1–24 ACTH (Cortysyn) in sodium depleted normal man. J Clin Endocrinol Metab. 1973; 36: 30–35
   PubMed Web of Science ®Google Scholar